Table 5.

ACC/AHA recommendations to perform angioplasty and stent in ATS-RVH

Adapted from Hirsch AT, et al. ACC/AHA 2005 Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): A Collaborative Report from the American Association for Vascular Surgery/Society for Vascular Surgery. Soc. J Am Coll Cardiol. 2006;47:1239–312 [33]

Indication	Class of recommendation/level of evidence
An asymptomatic bilateral or viable kidney with a hemodynamically significant RAS	IIb/C
Patients with hemodynamically significant RAS and accelerated HT, resistant HT, malignant HT, HT with an unexplained unilateral small kidney, and HT with intolerance to medication	IIa/C
RAS and progressive chronic kidney disease with bilateral RAS or a RAS to a solitary functioning kidney	IIa/B
Patients with RAS and chronic renal insufficiency with unilateral RAS	IIb/C
Patients with hemodynamically significant RAS and recurrent, unexplained congestive heart failure or sudden, unexplained pulmonary edema	I/B
Patients with hemodynamically significant RAS and unstable angina	IIa/B
Renal stent placement is indicated for ostial atherosclerotic RAS lesions that meet the clinical criteria for intervention	I/B

ATS-RVH atherosclerotic renovascular hypertension, RAS renal artery stenosis, HT hypertension